McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer

McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.

“For the past five years, Bansi has been a critical member of our executive team and has played an important role in key acquisitions and the evolution of our strategy to reposition McKesson in a rapidly-evolving market,” said Brian Tyler, Chief Executive Officer, McKesson. “We are grateful for his many contributions which have strengthened our core business and created new areas of growth. With the recent completion of our successful exit from Change Healthcare, and in the context of the company’s headquarters move to Dallas, Bansi and I agreed that this was the right time for this transition. We appreciate Bansi’s commitment to remain with the company for an interim period to assist with the transition of his responsibilities and wish him all the best as he begins his successful next chapter.”

Prior to joining McKesson in 2015, Nagji served as a principal of Deloitte Consulting, LLP where he led the U.S. Strategy Service Line and the Global practice of Monitor Deloitte, which was formed by the global merger of Monitor Group with Deloitte in January 2013. He was instrumental in the integration of Monitor into Deloitte’s operations. Before the merger with Deloitte, Nagji was president of Monitor Group. Nagji has served on several boards, including Change Healthcare, Inc.

About McKesson Corporation

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005681/en/

Holly Weiss, 972-969-9174 (Investors) [e-mail] David Matthews, 214-952-0833 (Media) [e-mail]